'Phantom recall'

Controversy grows over 'phantom recall'

The maker of Motrin faces mounting accusations that it hired people to buy up faulty medicine.

FDA under fire, too 

Also: 

• Exec resigns, hearing set
• More on 'phantom recall'
• Global drug safety bill